|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_ocn995357871 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170728s2017 nyu o 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d N$T
|d OCLCF
|d AGLDB
|d IGB
|d AUW
|d BTN
|d MHW
|d INTCL
|d SNK
|d G3B
|d S8I
|d S8J
|d STF
|d D6H
|d M8D
|d OCLCQ
|d AJS
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781536122589
|q (electronic bk.)
|
| 020 |
|
|
|a 1536122580
|q (electronic bk.)
|
| 020 |
|
|
|z 9781536122497
|q (print)
|
| 035 |
|
|
|a (OCoLC)995357871
|
| 050 |
|
4 |
|a RC267
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99/400727
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Horizons in cancer research.
|n Volume 68 /
|c Hiroto S. Watanbe, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c 2017.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (Ebsco, viewed August 22, 2017).
|
| 505 |
0 |
|
|a Preface; Chapter 1; Multimodal Treatment of High Grade Glioma; Federico Caporlingua1,*, MD, Alessandro Caporlingua1, MD, Alessandra Marongiu2, MD, Maria Pia Tropeano1, MD and Maurizio Salvati3; 1. Epidemiology; 2. Imaging of HGG; 3. Molecular Classification and Implications for Personalized Therapy in Glioma; 3.1. GBM Classification; 3.1.1. Primary versus Secondary GBM; 3.1.2. GBM Subtypes Based on Molecular Profiling; 3.2. Genetic and Epigenetic Mutations; 3.2.1. IDH1 and IDH2 Mutations; 3.2.2. O6-Methylguanine-DNA Methyltransferase (MGMT) Methylation
|
| 505 |
8 |
|
|a 3.2.3. Detection of 1p/19q Co-DeletionSurgical Treatment; 4.1. Surgery in the Elder Patient; 4.2. Surgical Management of Recurrences; 5. Principles of Chemotherapy and Radiotherapy; 5.1. Limitations of Chemotherapy; 5.2. Pharmacology of Commonly Used Agents; 5.2.1. Alkylating Agents; Temozolomide; Nitrosoureas; 5.2.2. Alkaloids; Vincristine; 5.2.3. Topoisomerase Inhibitors; Etoposide; 6. Epilepsy in HHGs; 6.1. Management of Epileptic Seizures in HGG; 6.1.1. Surgery; 6.1.2. Radiotherapy and Chemotherapy; 7. Future Scenarios; Conclusion; References; Chapter 2
|
| 505 |
8 |
|
|a Metastasis Suppressor Genes: Function and RegulationPatricio Barros-Núñez, Mónica Alejandra Rosales-Reynoso and Sofía Dumois-Petersen; Abstract; Introduction; Metastasis Development; Dissociation Phase; Invasion Phase; Intravasation Phase; Survival in Circulation Phase; Extravasation Phase; Dormancy Phase; Metastasis Suppression; Metastasis Suppressor Genes; Membrane-Bound Metastasis Suppressors; Nuclear Metastasis Suppressor Genes; Cytoplasmic Metastasis Suppressor Genes; Epigenetic Mechanisms and Metastasis Suppressor Genes; Clinical Implications; References; Chapter 3
|
| 505 |
8 |
|
|a Pineal Gland Secretion: The Regulation and Therapeutic Role in CancerMunibah Qureshi, Armughan Haider and Adeeb Shehzad*; Abstract; 1. Introduction; 1.1. Pineal Gland; 1.2. Anatomy; 1.3. Histology; 1.4. Innervations; 1.4.1. Sympathetic Innervations; 1.4.2. Non-Sympathetic Innervation of Pineal Gland; 1.4.3. Parasympathetic Innervations of Pineal Gland; 1.4.4. Trigeminal Ganglion; 1.5. Function of Pineal Body; 2. Secretion: Melatonin, Synthesis and Regulation; 2.1. Synthesis; 2.2. Regulation; 2.3. Elimination; 3. Therapeutic Implications; 3.1. Melatonin Therapeutic Role in Cancer
|
| 505 |
8 |
|
|a ConclusionReferences; Chapter 4; Oncolytic Virotherapies in Thoracic Cancers; Zeeshan Ahmad and Robert A. Kratzke*; Abstract; Introduction; Viral Targeting of Tumor Cells; Development of Attenuated Viruses; Oncolytic Viruses Induce Intrinsic Apoptosis in Cancer Cells; Oncolytic Virotherapy Combined with Immunotherapy; Oncolytic Virotherapy in Malignant Pleural Mesothileoma; Measles Virus; Measles-Induced Immune Suppression; Role of Dendritic Cells in Cancer Immunetherapy; Role of Type I Interferons; Sodium Ion Symporter; Newcastle Disease Virus; Oncolyic Virotherapy in Lung Cancer
|
| 500 |
|
|
|a Includes index.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cancer
|x Research.
|
| 650 |
|
0 |
|a Cancer
|x Treatment.
|
| 650 |
|
6 |
|a Cancer
|x Recherche.
|
| 650 |
|
6 |
|a Cancer
|x Traitement.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Cancer
|x Research.
|2 fast
|0 (OCoLC)fst00845497
|
| 650 |
|
7 |
|a Cancer
|x Treatment.
|2 fast
|0 (OCoLC)fst00845538
|
| 700 |
1 |
|
|a Watanbe, Hiroto S.,
|e editor.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1562904
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4926882
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1562904
|
| 994 |
|
|
|a 92
|b IZTAP
|
